Viral hepatitis in Asia-Pacific: a post-COVID-19 reset.
Wallace J, Hamid S, Mohamed R, Wong T.
Hepatitis B Hepatitis C COVID-19
Evaluation of an Online Training Program on COVID-19 for Health Workers in Papua New Guinea
Mohamed Y, Hezeri P, Kama H, Mills K, Walker S, Hau'ofa N, Amol C, Jones M, du Cros P, Lin YD
COVID-19
COVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort study.
Hall VG, Sim BZ, Lim C, Hocking C, Teo T, Runnegar N, Boan P, Heath CH, Rainey N, Lyle M, Steer C, Liu E, Doig C, Drummond K, Charles PGP, See K, Lim LL, Shum O, Bak N, Mclachlan SA, Singh KP, Laundy N, Gallagher J, Stewart M, Saunders NR, Klimevski E, Demajo J, Reynolds G, Thursky KA, Worth LJ, Spelman T, Yong MK, Slavin MA, Teh BW
COVID-19
Patients' access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study.
Yee WL, Bowring A, Draper B, O'Keefe D, Htay H, Myint KT, Aung HWP, Win YY, Sein YY, Mary M, Lin A, Pedrana A, Hellard M
Hepatitis C
COVID-19 adenoviral vector vaccination elicits a robust memory B cell response with the capacity to recognize Omicron BA.2 and BA.5 variants.
Fryer HA, Hartley GE, Edwards ESJ, Varese N, Boo I, Bornheimer SJ, Hogarth PM, Drummer HE, O'Hehir RE, van Zelm MC
COVID-19